Siv Lise Bedringaas

Living Under Threat of a Demolition Order

Siv Lise Bedringaas, 2016 .

4-Alkylated Silver–N-Heterocyclic Carbene (NHC) Complexes with Cytotoxic Effects in Leukemia Cells

Siv Lise Bedringaas, H. Bjørsvik, B. Gjertsen, 2015, ChemMedChem.

The members of the Gjertsen-lab are all thanked for creating the best working environment imaginable !

Siv Lise Bedringaas, T. Bredholt, J. Skavland, 2006 .

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation

Siv Lise Bedringaas, B. Gjertsen, R. Hovland, 2021, Molecular oncology.

Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML).

Siv Lise Bedringaas, B. Gjertsen, G. Sjøholt, 2006, Current pharmaceutical biotechnology.

Phosphoprotein DIGE profiles reflect blast differentiation, cytogenetic risk stratification, FLT3/NPM1 mutations and therapy response in acute myeloid leukaemia.

Siv Lise Bedringaas, Ø. Bruserud, B. Gjertsen, 2018, Journal of proteomics.